LP(A) AND CARDIOVASCULAR OUTCOMES: AN ANALYSIS FROM THE ODYSSEY OUTCOMES TRIAL

被引：15

作者：

Bittner, Vera ^{[1
]}

Szarek, Michael ^{[2
]}

Aylward, Philip E. ^{[3
]}

Bhatt, Deepak L. ^{[4
,5
]}

Diaz, Rafael ^{[6
]}

Fras, Zlatko ^{[7
]}

Goodman, Shaun ^{[8
]}

Hanotin, Corinne ^{[10
]}

Harrington, Robert ^{[9
]}

Jukema, J. W. ^{[11
]}

Loizeau, Virginie ^{[10
]}

Moriarty, Patrick ^{[12
]}

Moryusef, Angele ^{[13
]}

Pordy, Robert ^{[14
]}

Roe, Matthew T. ^{[15
]}

Sinnaeve, Peter ^{[16
]}

White, Harvey D. ^{[17
]}

Zahger, Doron ^{[18
]}

Zeiher, Andreas ^{[19
]}

Steg, Ph G. ^{[20
]}

Schwartz, Gregory ^{[21
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] Suny Downstate Med Ctr, New York, NY USA

[3] Flinders Univ & Med Ctr, South Australian Hlth & Med Res Inst, Adelaide, SA 5001, Australia

[4] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA

[5] Harvard Med Sch, Boston, MA USA

[6] Estudios Cardiol Latinoamer, Rosario, Santa Fe, Argentina

[7] Univ Ljubljana, Ljubljana, Slovenia

[8] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada

[9] Stanford Univ, Stanford, CA 94305 USA

[10] Sanofi, Paris, France

[11] Leiden Univ, Med Ctr, Leiden, Netherlands

[12] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA

[13] Sanofi, Bridgewater, NJ USA

[14] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[15] Duke Univ, Duke Clin Res Inst, Durham, NC USA

[16] UZ Leuven, Leuven, Belgium

[17] Auckland City Hosp, Green Lane Cardiovasc Serv, Auckland, New Zealand

[18] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Beer Sheva, Israel

[19] Goethe Univ, Frankfurt, Germany

[20] Hop Bicetre, AP HP, Paris, France

[21] Univ Colorado, Aurora, CO USA

来源：

ATHEROSCLEROSIS SUPPLEMENTS | 2018年 / 32卷

关键词：

D O I：

10.1016/j.atherosclerosissup.2018.04.072

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

C3-5.01

引用

页码：24 / 25

页数：2

共 50 条

[21] The ODYSSEY OUTCOMES study
Coppini, Lucia
Musumeci, Giuseppe
GIORNALE ITALIANO DI CARDIOLOGIA, 2019, 20 (04) : 187 - 189
[22] The COLchicine Cardiovascular Outcomes Trial (COLCOT)
Tardif, Jean-Claude
Kouz, Simon
Waters, David D.
Diaz, Rafael
Maggioni, Aldo P.
Pinto, Fausto J.
Gamra, Habib
Kiwan, Ghassan S.
Berry, Colin
Lopez-Sendon, Jose Luis
Ibrahim, Reda
Koenig, Wolfgang
Ostadal, Petr
Gregoire, Jean C.
Provencher, Mylene
Cossette, Marieve
Nozza, Anna
Blondeau, Lucie
L'Allier, Philippe L.
Guertin, Marie-Claude
Roubille, Francois
CIRCULATION, 2019, 140 (25) : E966 - E966
[23] Cardiovascular Outcomes Trials Update: Insights from the DEVOTE Trial
Bilal, Anika
Pratley, Richard E.
CURRENT DIABETES REPORTS, 2018, 18 (11)
[24] Cardiovascular Outcomes Trials Update: Insights from the DEVOTE Trial
Anika Bilal
Richard E. Pratley
Current Diabetes Reports, 2018, 18
[25] EFFECTS OF ALIROCUMAB IN PATIENTS WITH RECENT ACS AND A HISTORY OF HEART FAILURE: AN ANALYSIS OF THE ODYSSEY OUTCOMES TRIAL
White, Harvey D.
Schwartz, Gregory
Szarek, Michael
Bhatt, Deepak
Bittner, Vera
Chiang, Chern-En
Diaz, Rafael
Goodman, Shaun
Harrington, Robert
Jukema, Johan Wouter
Loy, Megan
Pordy, Robert
Ristic, Arsen
Yusoff, Khalid
Zeiher, Andreas
Steg, Philippe Gabriel
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 143 - 143
[26] Relation of Lipoprotein(a) Levels to Incident Diabetes and Modification by Alirocumab Treatment: An Analysis of the Odyssey Outcomes Trial
Schwartz, Gregory G.
Szarek, Michael
Baccara-Dinet, Marie
Bittner, Vera A.
Bhatt, Deepak L.
Diaz, Rafael
Goodman, Shaun G.
Harrington, Robert A.
Jukema, J. Wouter W.
Manvelian, Garen
Pordy, Robert
White, Harvey D.
Zeiher, Andreas M.
Steg, Philippe G.
CIRCULATION, 2020, 142
[27] Cost-Effectiveness of Alirocumab A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial
Kazi, Dhruv S.
Penko, Joanne
Coxson, Pamela G.
Guzman, David
Wei, Pengxiao C.
Bibbins-Domingo, Kirsten
ANNALS OF INTERNAL MEDICINE, 2019, 170 (04) : 221 - +
[28] Gender differences in cardiovascular risk, treatment, and outcomes: a post hoc analysis from the REWIND trial
Ferrannini, Giulia
Maldonado, Juan M.
Raha, Sohini
Rao-Melacini, Purnima
Khatun, Rutaba
Atisso, Charles
Shurzinske, Linda
Gerstein, Hertzel C.
Ryden, Lars
Bethel, M. Angelyn
SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2023, 57 (01)
[29] METABOLIC RISK FACTORS AND THE EFFECT OF ALIROCUMAB ON CARDIOVASCULAR EVENTS IN PATIENTS AFTER ACUTE CORONARY SYNDROME: AN ANALYSIS OF THE ODYSSEY OUTCOMES RANDOMIZED CONTROLLED TRIAL
Ostadal, Petr
Steg, Philippe Gabriel
Poulouin, Yan
Bhatt, Deepak
Bittner, Vera
Chua, Terrence
Diaz, Rafael
Goodman, Shaun
Harrington, Robert
Jukema, Johan Wouter
Karpov, Yuri
Pordy, Robert
Scemama, Michel
Szarek, Michael
White, Harvey D.
Zeiher, Andreas
Schwartz, Gregory
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 150 - 150
[30] Alirocumab and Cardiovascular Outcomes in Patients with Acute Coronary Syndrome (ACS) and Diabetes-Prespecified Analyses of ODYSSEY OUTCOMES
Ray, Kausik K.
Colhoun, Helen
Szarek, Michael
Baccara-Dinet, Marie
Bhatt, Deepak L.
Bittner, Vera
Budaj, Andrzej J.
Diaz, Rafael, Sr.
Goodman, Shaun G.
Hanotin, Corinne G.
Jukema, J. Wouter
Loizeau, Virginie
Lopes, Renato D.
Moryusef, Angele
Pordy, Robert
Ristic, Arsen D.
Roe, Matthew
Tunon, Jose
White, Harvey D.
Schwartz, Gregory G.
Steg, Philippe G.
DIABETES, 2018, 67

← 1 2 3 4 5 →